Michael Demurjian

Founder and CEO of Aspargo Laboratories Inc. at Tyme - Bedminster, NJ, US

Michael Demurjian's Colleagues at Tyme

David Carberry

Independent Board Member

Contact David Carberry

Barbara Galaini

Principal Accounting Officer and Corporate Controller

Contact Barbara Galaini

John Zucaro

Senior Vice President

Contact John Zucaro

Justin Lau

Director of Digital and Creative Services

Contact Justin Lau

Michele Korfin

Chief Operating Officer

Contact Michele Korfin

View All Michael Demurjian's Colleagues

Michael Demurjian's Contact Details

Email (Verified)
***@tymeinc.com

Get Michael Demurjian's Email Address

Mobile Number
(XXX) XXX-XXXX

Get Michael Demurjian's Mobile Number

HQ
212-461-2315

Location
New York, New York

Company
Tyme

Michael Demurjian's Company Details

Tyme

Bedminster, NJ, US • 20 - 49 Employees
BioTech/Drugs

TYME is an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™) that are intended to be broadly effective across tumor types and have low toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, the Company's therapeutic approach is designed to take advantage of a cancer cell's innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body's natural immune system. The Company is currently focused on developing its novel compound, SM-88. The Company believes that early clinical results demonstrated by SM-88 in multiple advanced cancers, including pancreatic, prostate, sarcomas, and breast, reinforce the potential of our emerging CMBT™ pipeline.For more information about the Company, visit www.tymeinc.com.

oncology pancreatic cancer cancer therapeutics biochemistry prostate cancer Cancer Metabolism-Based Compounds (CMBTsâ„¢) SM-88 Major Drugs Commercial Physical Research Biotechnology

Details about Tyme

Frequently Asked Questions about Michael Demurjian

Michael Demurjian currently works for Tyme.

Michael Demurjian's role at Tyme is Founder and CEO of Aspargo Laboratories Inc..

Michael Demurjian's email address is ***@tymeinc.com. To view Michael Demurjian's full email address, please signup to ConnectPlex.

Michael Demurjian works in the BioTech/Drugs industry.

Michael Demurjian's colleagues at Tyme are Ben Taylor, David Carberry, Barbara Galaini, John Zucaro, Justin Lau, Amanda Dickson, Michele Korfin and others.

Michael Demurjian's phone number is 212-461-2315